News
7h
MONTCO Today on MSNWSJ: Merck Makes $10 Billion Move as Keytruda Patent Expiration NearsMerck is making big pharma waves again with a $10 billion deal to acquire Verona Pharma, reports Colin Kellaher for the Wall ...
Two art-market analysts find a bear market for auctions sales of art: For three seasons now, 50% of artworks resold at ...
Pharmaceutical titan Merck & Co. Inc. has announced a landmark $10 billion acquisition of Verona Pharma plc, underscoring its ...
The pharmaceutical industry is staring down a major patent cliff, with key drugs from Merck (MRK), Bristol Myers Squibb (BMY), and Johnson & Johnson (JNJ) set to lose exclusivity by 2030. Yahoo ...
US Foods Holding stock hit an all-time high Friday on a report that the firm was mulling an acquisition of Performance Food ...
Investment firms in Boston and New York could see the biggest gains from the sale of a Raleigh drugmaker. Raleigh pharma ...
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.
Freshfields lands major US mandate advising Merck on $10bn Verona Pharma acquisition opposite Latham
Freshfields is advising Merck on its $10bn acquisition of respiratory-focused pharmaceutical company Verona Pharma, in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results